Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
John Kraus, MD, PhD
Advertisement
Articles by John Kraus, MD, PhD
How can we improve rural mental health?
Rejoyn was recently cleared by the FDA, making it the first prescription digital therapeutic for major depressive disorder.
New research explores ulotaront as an adjunctive therapy for adults with major depressive disorder.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Top 7 Atypical Psychedelics: A Brief Clinical Guide
2
Positive Phase 1b Results Demonstrate Clinical Proof-of-Concept for ALKS 7290 in Adults With ADHD
3
Positive Topline Phase 3 Study Results: Lumateperone for Manic Episodes in Bipolar I Disorder
4
New Analyses of HLP003 for the Adjunctive Treatment of MDD
5